1 re settings, but applicability to SARS-CoV-
2 is uncertain.
2 uments applied current breakpoints, 17 (
50%)
were uncertain how to change breakpoints, and 10 (29%) l
3 reasoning in populations where this
ability is uncertain.
4 s optimal to store more fat when food
access is uncertain, and we review the experimental literature
5 but to what extent these aims are
achievable is uncertain.
6 iomarker accuracy for Alzheimer disease (
AD)
is uncertain.
7 this association is independent of
adiposity is uncertain.The purpose of this study was to examine th
8 ders (TD/CTD) with autoimmune diseases (
ADs)
is uncertain.
9 e in children, adolescents, and young
adults are uncertain and that the evidence is insufficient to a
10 he evidence for dupilumab-related serious
AE is uncertain.
11 Its taxonomic
affinity is uncertain as it has a picornavirus-like cassette of e
12 e, if any, in the future treatment
algorithm is uncertain, given the availability of ruxolitinib and
13 rue penetrance of many of these rare
alleles is uncertain and might be over-estimated by clinical asc
14 n in those who receive medical therapy
alone is uncertain.
15 than pharmacologic thromboprophylaxis
alone is uncertain.
16 Durability of response
also was uncertain.
17 r patients with acute myeloid leukemia (
AML)
is uncertain.
18 ble for clinically relevant opioid
analgesia are uncertain.
19 ry embolism and major bleeding meta-
analyses are uncertain and no clear conclusion can be made other
20 ugh the nature of their last common
ancestor is uncertain.
21 after recovery from immune aplastic
anemia,
is uncertain.
22 ruled out earlier, but the optimal
approach is uncertain.
23 but the cost-effectiveness of this
approach is uncertain.
24 citation from out-of-hospital cardiac
arrest is uncertain for patients without ST-segment elevation.
25 interruption of antiretroviral therapy (
ART)
is uncertain.
26 d long-term consequences of septic
arthritis are uncertain.
27 but the factors underlying this
association are uncertain.
28 e role of eDNA, NETs, and IL-1beta in
asthma is uncertain.
29 ch as warming and altered water
availability is uncertain.
30 notably, the geographic origin of honey
bees is uncertain, as are the relationships among its constit
31 s of serious adverse events with
bevacizumab is uncertain because of the lack of specificity to condi
32 lesce, and while the effects on
biodiversity are uncertain, we hypothesize that they could eventually
33 countries who are at risk for preterm
birth are uncertain.
34 erventions in areas where hotspot
boundaries are uncertain.
35 t its efficacy in preventing CDI-related
BSI is uncertain.
36 sitivity of productivity to surface
buoyancy is uncertain and the relative importance of the physical
37 ion models for coronary artery disease (
CAD)
is uncertain.
38 er radical prostatectomy for prostate
cancer is uncertain.
39 Effects on nonmelanoma skin
cancer were uncertain for photodynamic therapy (3 trials, 93 pa
40 t of clinical Alzheimer-type dementia (
CATD)
are uncertain.
41 ying clinical Alzheimer-type dementia (
CATD)
are uncertain.
42 however, whether the relationship is
causal is uncertain.
43 abundant submucosal glands and goblet
cells are uncertain.
44 death 1 ligand 1 (PD-L1) ligation in T
cells are uncertain.
45 state, can suffice to yield functional
cells is uncertain.
46 nefits of population-based screening for
CKD are uncertain; that there is potential for harms; that s
47 major driver of Northern Hemisphere
climate,
is uncertain.
48 Guangdong, although phylogenetic
clustering is uncertain because of low virus genetic variation earl
49 cy and safety of rivaroxaban in this
context are uncertain.
50 arse, and the magnitude of this
contribution is uncertain(5-7).
51 global terrestrial response to this
cooling is uncertain.
52 st radiation, yet benefits, harms, and
costs are uncertain.
53 ion of PCP to tubulogenesis and
cystogenesis is uncertain, and two major questions remain unanswered.
54 tributes to the mnemonic functions of the
DG is uncertain.
55 elinating polyneuropathy (CIDP) and
diabetes is uncertain despite important diagnostic and management
56 ildren and animals, but its role in
diarrhea is uncertain.
57 The clinical importance of this
difference is uncertain.
58 The clinical importance of these
differences is uncertain and may require further study.
59 nsplantation or death due to kidney
disease,
is uncertain.
60 ent levels of adherence to social
distancing is uncertain.
61 Thus, the net effect on
diversification is uncertain.
62 Its role in diabetic nephropathy (
DN)
is uncertain.
63 s in plasma as virion-associated or free
DNA is uncertain.
64 with type 1 diabetes, its predominant
driver is uncertain.
65 duration of treatment and best partner
drug are uncertain.
66 d, for some modalities, long-term
durability is uncertain.
67 but whether antireflux surgery prevents
EAC is uncertain.
68 h relevance of this immunity blunting
effect are uncertain.
69 While the durability of the
effect is uncertain, this trial provides evidence that a low-co
70 tocyte effect, but the extent of this
effect is uncertain.
71 nfections in MSM, but its cost-
effectiveness is uncertain.
72 atment is expensive and TasP's
effectiveness is uncertain.
73 s and late at night, but their
effectiveness is uncertain where vectors bite outdoors and earlier in
74 epilepsy, its optimal strategies and
effects are uncertain.
75 mechanisms mediating these metabolic
effects are uncertain, the data suggest that beta3 agonists coul
76 icance of the observed immunological
effects is uncertain.
77 ply induces long-lasting symptomatic
effects is uncertain.
78 ife today, but how this system first
emerged is uncertain.
79 underlying shear stress-regulation of
EndMT are uncertain.
80 When an
environment is uncertain, humans and other animals benefit from prep
81 ce times adapt when the foraging
environment is uncertain.
82 ith asthma but the mechanism of
eosinophilia is uncertain as, although an increase in sputum IL-5 has
83 ent core, but the efficiency of such
erosion is uncertain and depends on both the immiscibility of he
84 Our
estimates are uncertain, and focus on underlying conditions rather
85 Risk scores and effect
estimates were uncertain.
86 United States (23.6%); however, the
etiology is uncertain.Objectives: In this study, we sought to unc
87 ming and recurrence intervals of such
events are uncertain.
88 Whether it prevents cardiovascular
events is uncertain.
89 ever, the clinical relevance of these
events is uncertain.
90 Yet, the
evidence is uncertain regarding the role of iron in the developme
91 is and pulmonary embolism), but the
evidence is uncertain.
92 although the magnitude of this gas
exchange is uncertain, and it is unclear whether oxygen and inert
93 The cause of ice
expansion is uncertain, but most likely it is related to increased
94 whether that contributes to repeat
expansion is uncertain.
95 The magnitude of this
feedback is uncertain, in part because warming-induced shifts in
96 odalities and function of regenerated
fibers is uncertain.
97 he remaining case with negative aCGH
finding was uncertain.
98 , the generalizability of the study
findings is uncertain and requires further research.
99 the cost-effectiveness of adding 5FC to
FLU is uncertain.
100 ng relative to stimulus onset ('
foreperiod')
was uncertain.
101 failure (HF) with reduced ejection
fraction is uncertain.
102 The structural basis of voltage
gating is uncertain because the resting state exists only at de
103 scle and the function of Smyd1a, in
general,
are uncertain.
104 ral therapy (ART), the of baseline
genotypes is uncertain.
105 one in the treatment of pharyngeal
gonorrhea is uncertain.
106 d the effectiveness of testing in this
group is uncertain.
107 remains so in both sexes and all age
groups is uncertain.
108 t human milk diets adequately support
growth is uncertain.
109 disrupt mitochondrial cristae, however,
has been uncertain.
110 ons of primary versus secondary sources,
has been uncertain in part because of limited knowledge of t
111 Hexon:VI stoichiometry
has been uncertain, and only fragments of VI have been ident
112 lities of uncultured ARMAN-like archaea
have been uncertain.
113 c, but their relative number and effect
have been uncertain.
114 evant characteristics of such an effort
have been uncertain.
115 However, researchers
have been uncertain about the underlying mechanisms for this
116 s on cardiac structure and function in
HFrEF are uncertain.
117 ission of human immunodeficiency virus (
HIV)
is uncertain.
118 ibutes to normal development and
homeostasis is uncertain.
119 f pirfenidone on death after
hospitalization is uncertain.
120 of cascading biochar use in animal
husbandry are uncertain but could provide 10-20% more mitigation t
121 ive pulmonary disease (COPD) and
hypercapnia is uncertain.
122 ntributes to the development of
hypertension is uncertain.
123 e management of isolated nocturnal
hypoxemia is uncertain.
124 ing high-dose inhaled corticosteroids (
ICSs)
is uncertain.
125 uman bocavirus (HBoV) in respiratory
illness is uncertain.
126 ng-term cost-effectiveness and budget
impact are uncertain.
127 efficacy, their health economic
implications are uncertain.
128 ,3); however, the magnitude of this
increase is uncertain.
129 kely dynamics following an initial
incursion are uncertain, especially the risk of continued spread,
130 Whether these effects occur in
infants is uncertain.
131 their effectiveness in controlling
infection is uncertain.
132 timize our behavior when sensory
information is uncertain.
133 the neural implications of this
inheritance are uncertain.
134 The cause of this
injury is uncertain but is suspected to be related to myocardit
135 ained in the face of altered resource
inputs is uncertain.
136 e value of performing FFR after
intervention is uncertain.
137 long-term effectiveness of the
intervention is uncertain.
138 o-called invasive pneumococcal disease;
IPD)
is uncertain.
139 It is uncertain if food antigen processing and immune activ
140 It is uncertain if occult nodal metastasis impacts survival
141 It is uncertain if the developmental window during which th
142 It is uncertain if the incidence of cirrhosis has previousl
143 It is uncertain if the risk of aortic dilation of varying d
144 It is uncertain if this is an attainable goal.
145 It is uncertain if this observed association arises through
146 It is uncertain to what extent HF confers an increased risk
147 It is uncertain what the best strategy is for offering popu
148 It is uncertain whether depressive symptoms are independent
149 It is uncertain whether infections in early pregnancy have
150 It is uncertain whether invasive ventilation can use lower
151 It is uncertain whether or not low to moderate glucocortico
152 It is uncertain whether such mangrove expansions are due to
153 It is uncertain whether this association is attributable to
154 It is uncertain whether this risk has changed in the era of
155 Although
it is uncertain if the association is causal, fatigue is a
156 range of mechanical stimuli, however, and
it is uncertain how differences in tension between the inne
157 vidual PUFA has barely been examined, and
it is uncertain which bacteria are truly involved in biohyd
158 ganic carbon to the modern biosphere, but
it is uncertain when this metabolism originated.
159 but
it is uncertain whether cancers in vivo depend on glutamine
160 L2 are posttranslationally modified, but
it is uncertain whether these modifications affect HPV infe
161 Currently,
it is uncertain whether this association also occurs in chi
162 Thus, in HD,
it is uncertain whether the RRM2B modifier effect on timing
163 isk of arterial thromboembolism; however,
it is uncertain when this excess risk begins.
164 However,
it is uncertain whether alpha4 integrins are also required
165 However,
it is uncertain whether management action prompted by a cha
166 However,
it is uncertain whether MP-TCP may cause inflammation and s
167 However,
it is uncertain which patient groups benefit the most from
168 e of co-occurrence of asthma and obesity,
it is uncertain whether asthma contributes to the developme
169 o reduce subsequent spontaneous seizures,
it is uncertain whether targeting miRNAs at chronic stages
170 arch performed outside the United States,
it is uncertain whether these findings also reflect the US
171 d between New York and comparison states,
it is uncertain whether these findings are generalizable to
172 However,
it was uncertain what such activation reflected.
173 ey neuroprotective function of these
kinases is uncertain.
174 redicting renal and patient outcomes in
LCCN is uncertain.
175 ug-susceptible (DS-)TB on a population
level is uncertain.
176 an be faithfully captured in stem cell
lines is uncertain.
177 ewer complications or to increased
longevity is uncertain.
178 (LCLs) evolve from the infected
lymphocytes is uncertain.
179 earch and their relevance to decision
making is uncertain.
180 a warning indication that the conclusion
may be uncertain.
181 The exact
mechanism is uncertain.
182 The underlying neural
mechanisms are uncertain, but genotype differences in medial tempor
183 D neuropathology, but the precise
mechanisms are uncertain.
184 cular disease (CVD), and all-cause
mortality are uncertain.
185 min K antagonist oral anticoagulants (
NOACs)
is uncertain, as they have not been compared directly in
186 Nurses were uncertain but enthusiastic about educational and te
187 ECM affects macrophage phenotype in
obesity is uncertain.
188 The significance of these
observations is uncertain, but the predominantly calcific morphology
189 long-term osteoporosis drug treatment (
ODT)
is uncertain.
190 Status of the flap after surgery
often is uncertain.
191 als with oral squamous cell carcinoma (
OSCC)
is uncertain.
192 ibility in those cases which would
otherwise be uncertain.
193 ther it results in improved clinical
outcome is uncertain.
194 systolic blood pressure for optimal
outcome is uncertain.
195 y on vaccine effectiveness (VE) and
outcomes is uncertain.
196 uces death and other cardiovascular
outcomes is uncertain.
197 m serum, but its effect on clinical
outcomes is uncertain.
198 surgery, but the effect on clinical
outcomes is uncertain.
199 nts, but the impact of DGF on graft
outcomes is uncertain.
200 ffect of discharge delay on patient
outcomes is uncertain.Objectives: To investigate the association
201 nitial therapy influences long-term
outcomes is uncertain.
202 ve, and because its relationship to
outcomes is uncertain.
203 treatment affected patient-reported
outcomes was uncertain; those results from the trial are reported
204 The effects on other
outcomes were uncertain.
205 here the location and timing of odor
packets are uncertain, remains unclear.
206 conditions, but its effects on low back
pain are uncertain.
207 diagnosis when the presence of
parkinsonism is uncertain.
208 f adverse RV remodeling in COVID-19
patients is uncertain.
209 oral anticoagulation (OAC) in ESRD
patients is uncertain.
210 efit of thromboprophylaxis in these
patients is uncertain.
211 l anticoagulation strategy in these
patients is uncertain.
212 rnative reading frame (ARF)-derived
peptides is uncertain.
213 ariables, WMH load and cognitive
performance are uncertain.
214 entions can improve oral vaccine
performance is uncertain.
215 ealth consequences of exposure to
pesticides are uncertain and subject to much debate.
216 entity of these early anoxygenic
phototrophs is uncertain, including whether or not they remain extan
217 ms of parkinsonism when the clinical
picture is uncertain.
218 omes for whom invasive evaluation is
planned are uncertain.
219 their applicability in the Asian
population is uncertain.
220 to study drugs or low risk in the
population is uncertain.
221 se on wheat yield in regions of high
poverty are uncertain.
222 of prophylactic hemoclipping on delayed
PPB is uncertain.
223 rimary progressive multiple sclerosis (
PPMS)
is uncertain.
224 beyond a common vascular risk factor
profile is uncertain.
225 effect of hospitalization-based
prophylaxis are uncertain.
226 prostatic hyperplasia (BPH) and
prostatitis is uncertain.
227 efore, inducing population (herd)
protection is uncertain.
228 tabolic change and change in
psychopathology is uncertain.
229 al effect on long-term quality of life (
QOL)
is uncertain.
230 ut its comparability to sleep
questionnaires is uncertain.
231 The magnitude of increase in breakdown
rates is uncertain, given differences in litter quality and mi
232 ital volume influences re-intervention
rates is uncertain.
233 ever, the effect of PICSI on livebirth
rates is uncertain.
234 ncreased risk of lip cancer, but the
reasons are uncertain.
235 ality after stroke than men, but the
reasons are uncertain.
236 ity is affected by long-term thermal
regimes is uncertain.
237 fects were small, and the clinical
relevance is uncertain, although polygenic score analyses may prov
238 ncluding kinetic energy (KE), and
remodeling is uncertain.
239 f sacubitril-valsartan on cardiac
remodeling is uncertain.
240 CRC-related death following adenoma
removal are uncertain.
241 Yet, many
researchers are uncertain about how to approach scientific storytell
242 ho have more-extensive HIV-1 drug
resistance are uncertain.
243 on and anxiety disorders, but
responsiveness is uncertain and side effects often lead to discontinuat
244 R 0.70; 95% CI 0.18-2.74), but these
results are uncertain.
245 function and subsequent roles in cancer
risk are uncertain.
246 fects on long-term mortality and stroke
risk are uncertain.
247 lin analogs and increased breast cancer
risk is uncertain, particularly with the short follow-up in p
248 diac function to this increased disease
risk is uncertain.
249 y associated with ACR, but their causal
role is uncertain.
250 nctional recovery, but their functional
role is uncertain.
251 a, although whether they play a primary
role is uncertain.
252 ing and repeated vaccination, but their
role is uncertain.
253 for type 1 retinopathy of prematurity (
ROP)
are uncertain.
254 ery is valuable where feasibility and
safety are uncertain.
255 ibrillator (ICD) implantation to prevent
SCD is uncertain.
256 ry detection mechanism of this compass
sense is uncertain but appears to involve the quantum spin dyn
257 significance of albuminuria in this
setting is uncertain and should not necessarily rule out EVR-bas
258 lizability of the findings to other
settings is uncertain, and the sample was small.
259 mple, and generalizability to other
settings is uncertain.
260 ts with stable ischemic heart disease (
SIHD)
are uncertain, as prior studies have been based on selec
261 oach we take here relies on limited data,
so is uncertain, but it provides cheap, safe and direct evi
262 ney's clearance of tubular secretory
solutes is uncertain.
263 when the time of occurrence of the test
song was uncertain.
264 The infection's
source was uncertain until genomic analysis of the fungal isola
265 om the blood-stream to the FDC in the
spleen is uncertain.
266 ld be valuable whenever the optimal
strategy is uncertain.
267 test positives, and optimal testing
strategy is uncertain.
268 of recurrent stroke after cryptogenic
stroke is uncertain.
269 13)) and for small events even its
structure is uncertain(14).
270 ute equally to all ischaemic stroke
subtypes is uncertain.
271 functional diversity of the AAA+
superfamily were uncertain.
272 ve coaching skills among practicing
surgeons is uncertain.
273 ple with acute respiratory distress
syndrome is uncertain according to the most recent data.
274 th non-ST elevation acute coronary
syndromes are uncertain because these patients were excluded from
275 istory of these mating compatibility
systems is uncertain, particularly regarding the number and dire
276 ogical processes and are therapeutic
targets is uncertain.
277 ploitation) and trying out a new option
that is uncertain but potentially more rewarding (exploration
278 The role of psychological
therapies is uncertain.
279 function differ between these two
therapies is uncertain.
280 There are uncertain patterns of demand, and transfusion instit
281 As such,
there are uncertain benefits from therapies available in the c
282 learning about CS-US relationships when
they are uncertain.
283 pothermia, length of its use, and its
timing are uncertain.
284 the drivers of intratumoral immune
tolerance are uncertain.
285 icular assist devices and cardiac
transplant is uncertain.
286 ope, although the efficacy of this
treatment is uncertain.
287 st 24 hours, but the optimal duration of
TTM is uncertain.
288 The importance of NSGCT cell
type is uncertain.
289 The global distribution of Buruli
ulcer is uncertain and potentially wider than currently recogn
290 nd harms of screening for unhealthy drug
use are uncertain and that the balance of benefits and harms
291 t optimal strategies for out-of-hospital
use are uncertain.
292 However, their relative
utility is uncertain.
293 , but their role in color and spatial
vision is uncertain.
294 novirus-induced asthma exacerbations in
vivo are uncertain.
295 domain, can support membrane fusion in
vivo is uncertain, as is the precise role of Munc18-2 during
296 els and risk of venous thromboembolism (
VTE)
is uncertain.
297 nd in primary and secondary plant cell
walls is uncertain, but their presence enables further study o
298 We are uncertain as to the reason for this and do not know
299 or secondary effect of abnormal body
weight is uncertain.
300 therapy and stem-cell transplantation,
which are uncertain.